FARRELL STEPHEN C Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
12
Insider Buys Sum
$1.05M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of FARRELL STEPHEN C

Biography of FARRELL STEPHEN C

No biography is available at this moment.

2015-11-06PurchaseEterna Therapeutics Inc.
ERNA
director
50,000
0.8771%
$3.83$191,500-46.15%
2015-11-06PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
100,000
0.1251%
$3.83$383,000-21.88%
2014-10-08PurchaseEterna Therapeutics Inc.
ERNA
director
32,050
0.458%
$3.12$99,996-24.29%
2014-10-08PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
64,100
0.0906%
$3.12$199,992+11.75%
2013-09-12PurchaseEterna Therapeutics Inc.
ERNA
director
2,922
0.0516%
$3.86$11,276+69.23%
2013-09-12PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
5,844
0.0106%
$3.86$22,552-11.59%
2013-09-11PurchaseEterna Therapeutics Inc.
ERNA
director
8,291
0.1481%
$3.90$32,327+69.23%
2013-09-11PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
16,582
0.0298%
$3.90$64,653-12.95%
2013-08-20PurchaseEterna Therapeutics Inc.
ERNA
director
2,700
0.0452%
$3.66$9,878+73.68%
2013-08-20PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
5,400
0.0095%
$3.66$19,756-5.78%
2013-08-19PurchaseEterna Therapeutics Inc.
ERNA
director
1,487
0.0248%
$3.65$5,422+78.38%
2013-08-19PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
2,974
0.0053%
$3.65$10,843-3.7%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.